GlassScriptPhysician profile
Stephen Reilly Smith
NPI 1063402295
$3,522.11
in general payments reported to CMS, 2019-2025
18 companies · $326 in 2025
The $326 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $79.41 · 2021: $302 · 2022: $734 · 2023: $800 · 2024: $612 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,594 · Entertainment: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,593.94 |
| Entertainment | $144.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $410.69 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $344.08 | 2023-2025 | Eylea Hd, Eylea |
| Eyepoint US, INC. | $320.54 | 2022-2024 | |
| Genentech USA, INC. | $289.10 | 2022-2025 | Vabysmo |
| Astellas Pharma US INC | $281.61 | 2024 | Izervay |
| Biotissue Holdings INC. | $246.95 | 2022-2023 | |
| Optos, INC. | $243.10 | 2021-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Novartis Pharmaceuticals Corporation | $186.49 | 2019 | |
| Heidelberg Engineering, INC. | $184.27 | 2021 | |
| Mallinckrodt Hospital Products INC. | $172.27 | 2023-2024 | Acthar |
| Regeneron Pharmaceuticals, INC. | $135.01 | 2022 | |
| Allergan, INC. | $128.22 | 2019 | |
| Rxsight INC | $127.22 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Mallinckrodt Enterprises LLC | $119.31 | 2019 | |
| Aerie Pharmaceuticals, INC. | $117.87 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optovue, INC. | $100.00 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $75.45 | 2020 | |
| Alimera Sciences, INC. | $39.93 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.